Cite
HARVARD Citation
Arai, Y. et al. (n.d.). Improved prognosis with additional medium‐dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. American journal of hematology. 93 (1), pp. 47-57. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arai, Y. et al. (n.d.). Improved prognosis with additional medium‐dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. American journal of hematology. 93 (1), pp. 47-57. [Online].